» Articles » PMID: 27061302

Rates of Detection of Developmental Problems at the 18-month Well-baby Visit by Family Physicians' Using Four Evidence-based Screening Tools Compared to Usual Care: a Randomized Controlled Trial

Overview
Specialty Pediatrics
Date 2016 Apr 11
PMID 27061302
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early and regular developmental screening can improve children's development through early intervention but is insufficiently used. Most developmental problems are readily evident at the 18-month well-baby visit. This trial's purpose is to: (1) compare identification rates of developmental problems by GPs/family physicians using four evidence-based tools with non-evidence based screening, and (2) ascertain whether the four tools can be completed in 10-min pre-visit on a computer.

Methods: We compared two approaches to early identification via random assignment of 54 families to either: 'usual care' (informal judgment including ad-hoc milestones, n = 25); or (2) 'Evidence-based' care (use of four validated, accurate screening tools, n = 29), including: the Parents' Evaluation of Developmental Status (PEDS), the PEDS-Developmental Milestones (PEDS-DM), the Modified Checklist for Autism in Toddlers (M-CHAT) and PHQ9 (maternal depression).

Results: In the 'usual care' group four (16%) and in the evidence-based tools group 18 (62%) were identified as having a possible developmental problem. In the evidence-based tools group three infants were to be recalled at 24 months for language checks (no specialist referrals made). In the 'usual care' group four problems were identified: one child was referred for speech therapy, two to return to check language at 24 months and a mother to discuss depression. All forms were completed on-line within 10 min.

Conclusions: Despite higher early detection rates in the evidence-based care group, there were no differences in referral rates between evidence-based and usual-care groups. This suggests that clinicians: (1) override evidence-based screening results with informal judgment; and/or (2) need assistance understanding test results and making referrals. Possible solutions are improve the quality of information obtained from the screening process, improved training of physicians, improved support for individual practices and acceptance by the regional health authority for overall responsibility for screening and creation of a comprehensive network.

Citing Articles

Latest clinical frontiers related to autism diagnostic strategies.

Cortese S, Bellato A, Gabellone A, Marzulli L, Matera E, Parlatini V Cell Rep Med. 2025; 6(2):101916.

PMID: 39879991 PMC: 11866554. DOI: 10.1016/j.xcrm.2024.101916.


Exploring public health nurses' acceptability of clinical assessment tools in a Norwegian child health centre.

Barrett E, Laholt H, Lorem G, Wang C Prim Health Care Res Dev. 2024; 25:e10.

PMID: 38343358 PMC: 10894717. DOI: 10.1017/S146342362400001X.


Routine developmental screening in Australian general practice: a pilot study.

Alexander K, Mazza D BMC Prim Care. 2023; 24(1):143.

PMID: 37430184 PMC: 10331965. DOI: 10.1186/s12875-023-02093-7.


Dynamics of changes in motor development depending on the quality in the 3rd month of life.

Gajewska E, Naczk M, Naczk A, Sobieska M Front Public Health. 2022; 10:939195.

PMID: 36187673 PMC: 9523469. DOI: 10.3389/fpubh.2022.939195.


Effectiveness-implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol.

Long D, Gibbons K, Dow B, Best J, Webb K, Liley H BMJ Open. 2022; 12(7):e060714.

PMID: 35840297 PMC: 9295674. DOI: 10.1136/bmjopen-2021-060714.